Valuation: Retractable Technologies, Inc.

Market Cap 16.59M 14.87M 13.71M 12.45M 23.56M 1.56B 24.22M 164M 65.39M 833M 62.24M 60.92M 2.63B P/E 2024
-1.7x
P/E 2025 -1.8x
Enterprise Value -19.18M -17.2M -15.85M -14.4M -27.25M -1.8B -28.01M -190M -75.63M -964M -71.99M -70.46M -3.05B EV / Sales 2024
-0.69x
EV / Sales 2025 -0.33x
Free-Float
35.63%
Yield 2024 *
-
Yield 2025 -
1 day-1.07%
1 week-1.42%
Current month-1.95%
1 month-16.47%
3 months-17.31%
6 months-20.51%
Current year-28.25%
1 week 0.55
Extreme 0.551
0.59
1 month 0.55
Extreme 0.551
0.68
Current year 0.55
Extreme 0.551
0.79
1 year 0.55
Extreme 0.551
0.87
3 years 0.55
Extreme 0.551
1.34
5 years 0.55
Extreme 0.551
9.25
10 years 0.54
Extreme 0.54
21.5
Manager TitleAgeSince
Chief Executive Officer 75 09/05/1994
Director of Finance/CFO 57 01/04/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 75 09/05/1994
Director/Board Member 78 22/03/2005
Director/Board Member 57 01/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
14/11/25 Buy

Chief Executive Officer

5,731 0.0191%
11/11/25 Buy

Chief Executive Officer

100 0.0003%
5/11/25 Buy

Chief Executive Officer

7,500 0.0251%
Change 5-day change 1-year change 3-year change Capi.($)
-1.07%-1.42%-33.76%-45.14% 16.59M
-0.05%+0.97%-12.26%+17.55% 191B
-1.17%+2.74%+9.64%+43.73% 124B
-0.44%+4.42%-8.66%+18.52% 123B
-1.57%+1.82%-39.83%+7.26% 96.14B
+0.85%+2.41%-4.37%+76.50% 66.54B
-1.23%+7.29%+17.05%-9.39% 57.91B
-1.42%+3.66%-1.82%+62.49% 54.89B
+1.45%-2.29%-4.31%+54.80% 49.1B
+1.08%+3.41%+4.00%-4.71% 36.19B
Average -0.36%+2.01%-7.43%+22.16% 80B
Weighted average by Cap. -0.43%+2.37%-6.90%+27.85%

Financials

2024 2025
Net sales 33.05M 29.64M 27.32M 24.81M 46.95M 3.1B 48.26M 327M 130M 1.66B 124M 121M 5.25B 38.27M 34.32M 31.63M 28.72M 54.36M 3.59B 55.88M 379M 151M 1.92B 144M 141M 6.08B
Net income -11.89M -10.66M -9.82M -8.92M -16.89M -1.11B -17.36M -118M -46.87M -597M -44.61M -43.66M -1.89B -12.57M -11.27M -10.39M -9.43M -17.85M -1.18B -18.35M -124M -49.54M -631M -47.16M -46.16M -2B
Net Debt -43.33M -38.86M -35.81M -32.52M -61.55M -4.06B -63.27M -429M -171M -2.18B -163M -159M -6.88B -35.77M -32.08M -29.56M -26.85M -50.81M -3.35B -52.23M -354M -141M -1.8B -134M -131M -5.68B
Projected Income Statement - Annual - Retractable Technologies, Inc.
Logo Retractable Technologies, Inc.
Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
Employees
198
Date Price Change Volume
10/11/26 USD 0.5540 -1.07% 20,057
09/11/26 USD 0.5600 -0.96% 17,476
06/11/26 USD 0.5654 -0.11% 52,094
05/11/26 USD 0.5660 0.00% 65,113
04/11/26 USD 0.5660 +0.71% 32,747